Economic impact of infections in patients with cancer
The cost of caring for patients with cancer has been reported to total over $100 billion dollars per year . Patients who have cancer have high utilization rates of medical care and have more medical interventions than patients with non-cancer-related diagnoses . One study, that examined the costs associated with the treatment of cancer found treatment costs to be $29,708 a year .
KeywordsClin Oncol Chronic Lymphocytic Leukemia Febrile Neutropenia Neutropenic Fever Critical Pathway
Unable to display preview. Download preview PDF.
- 1.Leake AR. The economic impact of cancer. Nurse Practioner Forum, No. 4 (December), 1995, pp. 207–214.Google Scholar
- 7.DeVita, Hellman, Rosenburg (eds). Cancer: Principles and Practice of Oncology, 4th ed. 1993.Google Scholar
- 8.Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Natl Cancer Inst 1993;85:460–474.Google Scholar
- 14.Lawless GD. Health resources utilization in ABMT with and without G-CSF in stage III/IV breast cancer patients. Oncology 1995(Suppl.):107–110.Google Scholar
- 18.Sawamura N, Akagi E, Narakoa I, Masunaga Y, Yokoyama S, Saijo N. Significance of the bioclean room during treatment of lung cancer. Jpn J Cancer Chemother 1984;11:253–259.Google Scholar
- 25.Shulin D. Critical pathways. In: Kelley. ed. Textbook of Internal Medicine, 3rd ed. Philadelphia: Lippincott-Raven, 1997, pp. 237–241.Google Scholar
- 27.Tomiak A, Yau J, Huan S, et al. Duration of intravenous antibiotic and hospital stay for patients with febrile neutropenia after chemotherapy: Experience of Ottawa Regional Cancer Center. Proc Ann Mtg Am Soc Clin Oncol 1993;12:A1500.Google Scholar
- 28.El-Deiry W, Morris L. High cost of hospital admissions for cancer patients at low risk to develop complications from febrile neutropenia. Proc Ann Mtg Am Soc Clin Oncol 1993;12:A1606.Google Scholar